Ebola Vaccine Effective in African Clinical Trials – Consumer Health News

Ebola Vaccine Effective in African Clinical Trials – Consumer Health News

During a 2014-2016 Ebola outbreak, West Africa had nearly 29,000 cases and more than 11,000 deaths. About 20% of cases were in children under age 15, and those under 5 had a higher risk of dying than adults, researchers noted. The disease causes fever, aches, pains and unexplained hemorrhaging, bleeding or bruising. Researchers found that it was well tolerated and induced antibody responses 21 days after the second dose in 98% of participants. The immune responses persisted in adults for at least two years. “This study represents important progress in the development of an Ebola virus disease vaccine regimen for children, and contributes to the public health preparedness and response for Ebola outbreaks,” Afolabi said.

“The results show that this vaccine regimen has the potential to save many young lives,” he said in a school news release. “Working in tandem with Sierra Leone colleagues and the local communities, this is the first published study to evaluate this two-dose vaccine regime in a randomized controlled trial in children,” said study leader Dr. Muhammed Afolabi, an assistant professor at the London School of Hygiene & Tropical Medicine (LSHTM).

The EBOVAC-Salone study provides evidence for the potential of the two-dose regimen as a way to prevent Ebola in children and adults. The trial was conducted in the West African nation of Sierra Leone.

The findings contributed to the approval and marketing of the two-dose Ebola vaccine regimen in July 2020 by the European Medicines Agency, for both children and adults. It also contributed to prequalification in April 2021 by the World Health Organization (WHO). “The threat of future Ebola virus disease outbreaks is real and it’s important to remember that this disease has definitely not gone away,” said co-author Deborah Watson-Jones, a professor at LSHTM. “Despite the additional global challenges around COVID-19, we must not slow down efforts to find effective ways of preventing Ebola virus epidemics and, should outbreaks occur, of containing them rapidly.” “To protect people from Ebola, we will need a range of effective interventions,” said co-author Dr. Daniela Manno of LSHTM. “These findings support the additional strategy of providing an Ad26.ZEBOV booster to previously immunized individuals at the start of an Ebola virus disease outbreak.”

Adults participating in the first stage of the study were offered a booster dose of Ad26.ZEBOV two years after the first dose. Researchers reported it induced a strong immune response within a week. For the study, 43 adults received the Ad26.ZEBOV vaccine followed by the MVA-BN-Filo vaccine after 56 days. In the next stage, 400 adults and 576 children and teens were vaccinated with either that regimen or a single dose of a meningococcal vaccine followed by placebo on day 57.

The News Highlights

  • Ebola Vaccine Effective in African Clinical Trials – Consumer Health News
  • Check the latest Health news updates and information about health.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
In the latest “apology”, Facebook discloses security and safety chaos
In the latest “apology”, Facebook discloses security and safety chaos
Now, Facebook wants you to know it’s sorry and that it’s trying to do better. Facebook had it rough last week. Leaked documents—many leaked documents—formed ...
Henry Marroquin hopes to bring the focus of small business to Sherman City Council
Henry Marroquin hopes to bring the focus of small business to Sherman City Council
Marroquin said he would like to bridge a gap between the city and its growing Hispanic population. One of the larger hurdles for the community is a language ...
We know so far Microsoft Surface Duo 2 news, price, leaks and everything
We know so far Microsoft Surface Duo 2 news, price, leaks and everything
Now there are signs of a Microsoft Surface Duo 2 on the horizon, and it looks set to keep the same core selling points as the original Surface Duo, while ...
Next Month, Motorola will release the Moto Tab 8 with stock Android
Next Month, Motorola will release the Moto Tab 8 with stock Android
Moto Tab 8: specifications The upcoming Motorola Moto Tab 8 is reportedly a rebranded Lenovo Tab M8 FHD launched back in October 2019. The only notable ...
Gabby Petito’s final ‘odd text’ was sent from her phone. In the Warrant, it was revealed that
Gabby Petito’s final ‘odd text’ was sent from her phone. In the Warrant, it was revealed that
In the recently unsealed search warrant filed on Sept. 17 for an external hard drive in the van Petito was traveling in, police wrote that her mother, Nicole ...
One UI 4.0 Beta: Android 12’s Top New Features [Video]
One UI 4.0 Beta: Android 12’s Top New Features
It’s worth noting that unlike the Android 12 Beta builds that have been rolling out to the Pixel series with some significant changes, One UI 4.0 is less ...
House OKs Debt and Funding Plan, Inviting Collide With GOP
House OKs Debt and Funding Plan, Inviting Collide With GOP
While suspending the debt ceiling allows the government to meet financial obligations already incurred, Republicans argued it would also facilitate a ...
Baptist Health Corbin awards 22 academic scholarships
Baptist Health Corbin awards 22 academic scholarships
Jordan Wilson Dorothy James John Lowe Sarah Ashley Emily Davenport Ryleigh Swafford Madicyn Wynn Makayla Mack Rhiannon Spradlin Cody Evans Kara Grisell Dylan ...
Contra Costa supervisors refuse to extend moratorium on eviction COVID-19 |  News
Contra Costa supervisors refuse to extend moratorium on eviction COVID-19 | News
Board chair Diane Burgis said she was sympathetic to the people that are still hurting, but “I believe we need to move on. The economy hasn’t fully ...
Microsoft’s new flagship laptop, the Surface Laptop Studio, is a formidable machine
Microsoft’s new flagship laptop, the Surface Laptop Studio, is a formidable machine
“Surface Laptop Studio is the most powerful Surface we’ve ever built,” says Pete Kyriacou, vice president of devices at Microsoft. “It is the culmination of ...
Show next
Compsmag - Latest News from tech, business and health
Logo